InvestorsHub Logo

Rawnoc

12/03/16 7:15 PM

#127616 RE: Trendliner #127615

Actually Seymour did address it in the letter:

"We have been working on developing a number of analysis and characterization assays necessary for enabling batch-to-batch consistent production of our materials since moving to the new campus."

Translation in plain English -- still no batch-to-batch consistent production. What Seymour "forgets" to mention is that without consistent production NNVC is dead in the water. No clinicals. Not even TOX.

The prototype results bullshit -- if one is inclined to believe them -- are completely worthless. Great prototype results are apparently easy with nanomedicine -- being able to make consistent batches to move onto the TOX stage is another story.

No wonder they didn't even bother hiring a virologist until recently. Why bother?

Its_lose_not_loose

12/03/16 9:04 PM

#127620 RE: Trendliner #127615

So why does it sell at more than three times that?


Somethings... well let me rephrase that... most things can't be explained with TA, at least not correctly. All the hocus pocus that people use TA for doesn't amount to a hill of beans. And one doesn't have to understand TA to know it's just iron pyrite.

Snowy_Owl

12/03/16 11:09 PM

#127621 RE: Trendliner #127615

You 'know' Gene reads this board? I suspect Gene is in the majority. Meaning he checks in once in awhile and skips the repetitious bullshit. Same stuff 7 x 24.

LOL. SMH.